A detailed history of Raymond James & Associates transactions in Zoetis Inc. stock. As of the latest transaction made, Raymond James & Associates holds 925,354 shares of ZTS stock, worth $169 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
925,354
Previous 794,419 16.48%
Holding current value
$169 Million
Previous $138 Million 31.28%
% of portfolio
0.11%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$172.58 - $196.48 $22.6 Million - $25.7 Million
130,935 Added 16.48%
925,354 $181 Million
Q2 2024

Jul 19, 2024

BUY
$145.54 - $178.83 $6.64 Million - $8.15 Million
45,597 Added 6.09%
794,419 $138 Million
Q1 2024

Apr 22, 2024

BUY
$165.67 - $199.94 $30.1 Million - $36.3 Million
181,689 Added 32.04%
748,822 $127 Million
Q4 2023

Jan 16, 2024

SELL
$151.44 - $200.09 $8.38 Million - $11.1 Million
-55,303 Reduced 8.88%
567,133 $112 Million
Q3 2023

Oct 24, 2023

BUY
$167.14 - $192.77 $1.78 Million - $2.05 Million
10,624 Added 1.74%
622,436 $108 Million
Q2 2023

Jul 25, 2023

SELL
$160.94 - $186.23 $910,598 - $1.05 Million
-5,658 Reduced 0.92%
611,812 $105 Million
Q1 2023

Apr 14, 2023

BUY
$145.48 - $175.02 $3.96 Million - $4.77 Million
27,229 Added 4.61%
617,470 $103 Million
Q4 2022

Feb 08, 2023

SELL
$131.14 - $157.47 $13.1 Million - $15.8 Million
-100,100 Reduced 14.5%
590,241 $86.5 Million
Q3 2022

Oct 25, 2022

SELL
$148.29 - $182.55 $5.7 Million - $7.02 Million
-38,468 Reduced 5.28%
690,341 $102 Million
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $18 Million - $23.1 Million
-115,627 Reduced 13.69%
728,809 $125 Million
Q1 2022

May 11, 2022

SELL
$181.39 - $234.03 $8.3 Million - $10.7 Million
-45,732 Reduced 5.14%
844,436 $159 Million
Q4 2021

Feb 08, 2022

BUY
$193.69 - $247.03 $3.81 Million - $4.86 Million
19,664 Added 2.26%
890,168 $217 Million
Q3 2021

Nov 02, 2021

SELL
$189.29 - $209.69 $2.73 Million - $3.03 Million
-14,429 Reduced 1.63%
870,504 $169 Million
Q2 2021

Aug 11, 2021

BUY
$155.9 - $187.99 $2.3 Million - $2.78 Million
14,768 Added 1.7%
884,933 $165 Million
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $5.86 Million - $6.89 Million
40,666 Added 4.9%
870,165 $137 Million
Q4 2020

Feb 12, 2021

SELL
$157.07 - $174.35 $6.22 Million - $6.91 Million
-39,617 Reduced 4.56%
829,499 $137 Million
Q3 2020

Nov 04, 2020

BUY
$137.1 - $165.37 $1.38 Million - $1.67 Million
10,072 Added 1.17%
869,116 $144 Million
Q2 2020

Jul 28, 2020

BUY
$111.92 - $142.53 $3.08 Million - $3.93 Million
27,554 Added 3.31%
859,044 $118 Million
Q1 2020

Apr 21, 2020

SELL
$92.66 - $144.94 $5.31 Million - $8.31 Million
-57,335 Reduced 6.45%
831,490 $97.9 Million
Q4 2019

Feb 12, 2020

BUY
$116.25 - $133.25 $4.81 Million - $5.51 Million
41,350 Added 4.88%
888,825 $118 Million
Q3 2019

Nov 07, 2019

BUY
$112.57 - $128.43 $3.23 Million - $3.68 Million
28,679 Added 3.5%
847,475 $106 Million
Q2 2019

Aug 06, 2019

SELL
$97.98 - $114.28 $4.29 Million - $5.01 Million
-43,804 Reduced 5.08%
818,796 $92.9 Million
Q1 2019

May 06, 2019

BUY
$81.56 - $100.67 $3.92 Million - $4.84 Million
48,065 Added 5.9%
862,600 $86.8 Million
Q4 2018

Feb 11, 2019

BUY
$79.28 - $95.27 $1.66 Million - $1.99 Million
20,911 Added 2.63%
814,535 $69.7 Million
Q3 2018

Nov 14, 2018

SELL
$83.5 - $93.23 $587,673 - $656,152
-7,038 Reduced 0.88%
793,624 $72.7 Million
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $10.5 Million - $11.7 Million
131,192 Added 19.6%
800,662 $68.2 Million
Q1 2018

May 14, 2018

BUY
$71.51 - $84.69 $1.81 Million - $2.14 Million
25,305 Added 3.93%
669,470 $55.9 Million
Q4 2017

Feb 14, 2018

BUY
$63.24 - $72.8 $3.16 Million - $3.64 Million
49,986 Added 8.41%
644,165 $46.4 Million
Q3 2017

Nov 13, 2017

BUY
$59.73 - $65.4 $3.22 Million - $3.52 Million
53,869 Added 9.97%
594,179 $37.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
540,310
540,310 $33.7 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $85.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.